SCHEMBL14046801

SCHEMBL14046801

COC(=O)[C@H](Cc1cnc[nH]1)NC(=O)/C=C/c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ NOS2 P35228 10/20 0.57
▸ NOS3 P29474 7/20 0.57
▸ NOS1 P29475 7/20 0.57
▸ ITGB2 P05107 1/20 0.50
▸ ICAM1 P05362 1/20 0.50
▸ ITGAL P20701 1/20 0.50
▸ HTR1D P28221 2/20 0.49
▸ HTR2C P28335 2/20 0.49
▸ HTR1E P28566 2/20 0.49
▸ HTR2B P41595 2/20 0.49
▸ HTR2A P28223 1/20 0.49
▸ HTR3A P46098 1/20 0.49
▸ CNR2 P34972 1/20 0.47
▸ TAS1R3 Q7RTX0 1/20 0.47
▸ TAS1R1 Q7RTX1 1/20 0.47
▸ HRH4 Q9H3N8 1/20 0.46
▸ HRH3 Q9Y5N1 1/20 0.46
▸ ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11158707 0.81 ITGB2 (0.58) ITGB2ICAM1ITGALHTR1DHTR2C
SCHEMBL4535076 0.80 HTR1D (0.48) ITGB2ICAM1ITGALHTR1DHTR2C
SCHEMBL29040563 0.80 NOS2 (0.84) NOS2NOS3NOS1CNR2
SCHEMBL29040561 0.80 NOS2 (0.84) NOS2NOS3NOS1CNR2
SCHEMBL7598348 0.80 ITGB2 (0.55) ITGB2ICAM1ITGALHTR1DHTR2C
SCHEMBL9875941 0.78 MME (0.59) HTR1DHTR2CHTR1EHTR2BHTR2A
SCHEMBL5808674 0.77 HTR1D (0.51) ITGB2ICAM1ITGALHTR1DHTR2C
SCHEMBL27342814 0.76 REN (0.56) ITGB2ICAM1ITGALHTR1DHTR2C
SCHEMBL1711193 0.76 NOS2 (0.73) NOS2NOS3NOS1CNR2
SCHEMBL2059180 0.76 SIRT2 (0.52) ITGB2ICAM1ITGALHTR1DHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1982716-A1 NOVEL HISTIDINE DERIVATIVE Nippon Zoki Pharmaceutical Co. Ltd. (JP) 2008-10-22 — — EP disclosed
Send feedback